- Home
- HI vs TWST Comparison
HI vs TWST Comparison
Compare HI & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HI
- TWST
- Stock Information
- Founded
- HI 2007
- TWST 2013
- Country
- HI United States
- TWST United States
- Employees
- HI N/A
- TWST N/A
- Industry
- HI Miscellaneous manufacturing industries
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HI Consumer Discretionary
- TWST Health Care
- Exchange
- HI Nasdaq
- TWST Nasdaq
- Market Cap
- HI 2.2B
- TWST 2.7B
- IPO Year
- HI N/A
- TWST 2018
- Fundamental
- Price
- HI $32.78
- TWST $36.89
- Analyst Decision
- HI Buy
- TWST Buy
- Analyst Count
- HI 3
- TWST 8
- Target Price
- HI $44.67
- TWST $51.63
- AVG Volume (30 Days)
- HI 401.6K
- TWST 767.9K
- Earning Date
- HI 11-13-2024
- TWST 11-18-2024
- Dividend Yield
- HI 2.72%
- TWST N/A
- EPS Growth
- HI N/A
- TWST N/A
- EPS
- HI N/A
- TWST N/A
- Revenue
- HI $3,182,800,000.00
- TWST $295,210,000.00
- Revenue This Year
- HI $14.37
- TWST $29.32
- Revenue Next Year
- HI N/A
- TWST $19.52
- P/E Ratio
- HI N/A
- TWST N/A
- Revenue Growth
- HI 12.63
- TWST 25.37
- 52 Week Low
- HI $25.11
- TWST $20.59
- 52 Week High
- HI $50.58
- TWST $60.90
- Technical
- Relative Strength Index (RSI)
- HI 63.85
- TWST 34.53
- Support Level
- HI $30.04
- TWST $44.79
- Resistance Level
- HI $35.33
- TWST $48.83
- Average True Range (ATR)
- HI 1.09
- TWST 2.41
- MACD
- HI 0.44
- TWST -0.51
- Stochastic Oscillator
- HI 68.00
- TWST 1.08
About HI Hillenbrand Inc
Hillenbrand Inc is a U.S.-based company that operates through three segments. The Advanced Process Solutions segment designs, develops, manufactures, and services engineered industrial equipment. The Molding Technology Solutions segment offers engineered and customized systems in plastic technology and processing. Batesville designs provides, and markets funeral services and solutions.
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.